Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease	Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, interstitial lung disease, lung disorder, respiratory system disorder, systemic lupus erythematosus	Recruiting	Phase 4	2026-01-27		NCT07077486

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Johns Hopkins Bloomberg School of Public Health	64
Rongchang Biopharmaceutical	1
Tongji Hospital	276
Wuhan Central Hospital	22
Wuhan Hospital of Traditional Chinese Medicine	6

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	71